The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population
Sena Alaeikhanehshir(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Jelle Wesseling(Leiden University Medical Center), Alexandra W. van den Belt‐Dusebout(The Netherlands Cancer Institute), Ellen Verschuur(Borstkankervereniging Nederland), Frederieke van Duijnhoven(The Netherlands Cancer Institute), Esther H. Lips(Leiden University Medical Center), Michael Schaapveld(The Netherlands Cancer Institute), Renée Schmitz(The Netherlands Cancer Institute), Maartje van Seijen(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital)
Cited by 7
Related Papers
Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype
|Journal of Clinical Oncology|2011|306
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)
|The Lancet Oncology|2007|278
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer
|Breast Cancer Research and Treatment|2009|256
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers
|British Journal of Cancer|2013|241